Nerdwallet Inc (NRDS) concluded trading on Thursday at a closing price of $11.38, with 4.25 million shares of worth about $48.33 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -5.13% during that period and on February 20, 2025 the price saw a loss of about -18.63%. Currently the company’s common shares owned by public are about 42.34M shares, out of which, 34.01M shares are available for trading.
Stock saw a price change of -16.11% in past 5 days and over the past one month there was a price change of -20.73%. Year-to-date (YTD), NRDS shares are showing a performance of -14.47% which decreased to -32.81% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $10.10 but also hit the highest price of $17.30 during that period. The average intraday trading volume for Nerdwallet Inc shares is 416.39K. The stock is currently trading -18.77% below its 20-day simple moving average (SMA20), while that difference is down -17.59% for SMA50 and it goes to -15.78% lower than SMA200.
Nerdwallet Inc (NASDAQ: NRDS) currently have 42.34M outstanding shares and institutions hold larger chunk of about 40.00% of that.
The stock has a current market capitalization of $835.37M and its 3Y-monthly beta is at 1.33. It has posted earnings per share of -$0.14 in the same period. It has Quick Ratio of 2.91 while making debt-to-equity ratio of 0.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for NRDS, volatility over the week remained 9.64% while standing at 5.14% over the month.
Stock’s fiscal year EPS is expected to drop by -20.00% while it is estimated to increase by 114.47% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Citigroup on May 03, 2023 offering a Neutral rating for the stock and assigned a target price range of between $15 and $14 to it. On November 29, 2021, Truist Initiated their recommendations, while on November 29, 2021, Oppenheimer Initiated their ratings for the stock with a price target of $30. Stock get an Equal-weight rating from Morgan Stanley on November 29, 2021.
